Sometimes called molecular photocopying, the polymerase chain reaction (PCR) is a fast and inexpensive technique used to amplify – copy – small segments of DNA. PCR is valuable in a number of laboratory and clinical techniques, including DNA fingerprinting, detection of bacteria or viruses, and diagnosis of genetic disorders. Gen Consulting Company が発表した市場調査によると, the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market is expected to reach approximately USD 5,264 百万, representing a CAGR of 8.5% 予測期間中 2022-2028.

このレポートは、現在の世界市場シナリオに関する詳細な分析と洞察を提供します。, latest trends and drivers into global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market. 市場規模などのさまざまな詳細について独自の洞察を提供します, 主要なトレンド, 競争環境, 成長率と市場セグメント. This study also provides an analysis of the impact of the COVID-19 crisis on the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics industry.

この業界レポートは、世界市場の市場推定と予測を提供します。, その後、製品の詳細な分析が行われます, と地域. The global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics can be segmented by product: 装置, キット. Kits was the largest revenue contributor to the global pcr for poc diagnostics market in 2021 and is anticipated to show the highest growth rate during the forecast period. Polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market is further segmented by region: アジア太平洋地域, ヨーロッパ, 北米, 世界のその他の地域 (行). North America is estimated to account for the largest share of the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.

製品別:
– 装置
– キット

地域別:
– アジア太平洋地域
– ヨーロッパ
– 北米
– 世界のその他の地域 (行)

The equipment market is further segmented into multi-kit, single kit. The single kit segment captured the largest share of the market in 2021 予測期間中もその優位性を維持すると予想されます. さらに, the kit market has been categorized into infectious disease, multi-analyte panels, sexually transmitted diseases (STDs), single analyte, その他. 研究によると, the single analyte segment had the largest share in the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.

The report has also analysed the competitive landscape of the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market with some of the key players being Abbott Laboratories Inc., バイオ・ラッド研究所, 株式会社, Cepheid, キアゲン N.V., ロシュ・ホールディングAG, とりわけ.
*無料サンプルをリクエストして企業の完全なリストを入手してください

歴史的 & 予測期間
この調査レポートは、以下の各セグメントの分析を提供します。 2018 に 2028 検討中 2021 基準年となる.

報告書の範囲
– To analyze and forecast the market size of the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.
– To classify and forecast the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market based on product, 領域.
– To identify drivers and challenges for the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.
– 合併などの競争展開を検討するため & 買収, 協定, コラボレーションとパートナーシップ, 等, in the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.
– To identify and analyze the profile of leading players operating in the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market.

このレポートを選択する理由
– Gain a reliable outlook of the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market forecasts from 2022 に 2028 シナリオ全体にわたって.
– 投資対象となる成長セグメントを特定する.
– 会社概要と市場データを通じて競合他社に先んじる.
– Excel 形式でのシナリオ全体の分析を容易にするための市場予測.
– 3ヶ月間の戦略コンサルティングとリサーチサポート.
– シングルユーザーライセンスに提供される印刷認証.